J B Chemicals & Pharmaceuticals (JBC) is a prominent player in the pharmaceutical industry, established in 1976 and headquartered in Maharashtra, India. The company manufactures and markets a diverse array of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). JBC operates multiple manufacturing plants across India, including in Thane, Belapur, Ankleshwar, Panoli, and Daman. Notable products include Metrogyl, Rantac, and Nicardia, which contribute significantly to its sales.
JBC has expanded its portfolio through strategic acquisitions and partnerships, including McDa Agro for agro-based products and the Azmarda brand from Novartis. It has also entered international markets with subsidiaries like Unique Pharmaceutical Laboratories in Moscow and a high stake in Biotech Laboratories in South Africa. The company has consistently launched new products, with recent additions in the gastrointestinal, gynecology, respiratory, and anti-diabetes sectors, and acquired stakes in niche portfolios from major pharmaceutical entities.